Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

551 indexed citations

Abstract

loading...

About

This paper, published in 2002, received 551 indexed citations. Written by Reginald V. Lord, Jan Brabender, David R. Gandara, Vicente Alberola, Carlos Camps, Manuel Dómine, F. Cardenal, José Miguel Sánchez, Paul H. Gumerlock and Miquel Tarón covering the research area of Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. It is primarily cited by scholars working on Molecular Biology (313 citations), Oncology (286 citations) and Pulmonary and Respiratory Medicine (280 citations). Published in PubMed.

In The Last Decade

doi.org/w37503338 →

Countries where authors are citing Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Specialization
Citations

This map shows the geographic impact of Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. more than expected).

Fields of papers citing Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w37503338.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026